We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+13.59%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$26.6B
AUM Growth
+$4.1B
(+18%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
4.73%
Top 10 Holdings %
Top 10 Hldgs %
24.22%
Holding
1,386
New
198
Increased
571
Reduced
426
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$116M |
| 2 |
Snowflake
SNOW
|
+$77.7M |
| 3 |
Zoom
ZM
|
+$73.8M |
| 4 |
Microsoft
MSFT
|
+$63.2M |
| 5 |
TE Connectivity
TEL
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$61M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$57M |
| 3 |
Intuitive Surgical
ISRG
|
+$47.7M |
| 4 |
Equinix
EQIX
|
+$40.2M |
| 5 |
AT&T
T
|
+$38.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Healthcare | 16.41% |
| 3 | Financials | 11.42% |
| 4 | Communication Services | 10.26% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Caesarstone
CSTE
$104M
| $385K | ﹤0.01% |
29,838
| – | – |
|
|
RNAM
1077
DELISTED
Avidity Biosciences
RNAM
| $384K | ﹤0.01% |
+14,000
| New | +$408K |
|
|
ADVM
1078
DELISTED
Adverum Biotechnologies
ADVM
| $380K | ﹤0.01% |
+3,250
| New | +$402K |
|
1079
Passage Bio
PASG
$14.5M
| $380K | ﹤0.01% |
+715
| New | +$286K |
|
1080
Charles River Laboratories
CRL
$13.5B
| $373K | ﹤0.01% |
+1,500
| New | +$357K |
|
1081
GDS Holdings
GDS
$6.54B
| $372K | ﹤0.01% |
4,115
+835
| +25% | +$74.2K |
|
1082
Melco Resorts & Entertainment
MLCO
$2.16B
| $370K | ﹤0.01% |
20,070
+2,553
| +15% | +$44.4K |
|
|
AMTI
1083
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $370K | ﹤0.01% |
+11,000
| New | +$349K |
|
|
EPZM
1084
DELISTED
Epizyme, Inc
EPZM
| $370K | ﹤0.01% |
32,300
+11,400
| +55% | +$141K |
|
|
PFPT
1085
DELISTED
Proofpoint, Inc.
PFPT
| $368K | ﹤0.01% |
2,800
-2,600
| -48% | -$285K |
|
1086
MacroGenics
MGNX
$249M
| $363K | ﹤0.01% |
16,200
+6,200
| +62% | +$143K |
|
1087
Compugen
CGEN
$221M
| $362K | ﹤0.01% |
30,000
| – | – |
|
|
ZGNX
1088
DELISTED
Zogenix, Inc.
ZGNX
| $362K | ﹤0.01% |
18,600
+7,000
| +60% | +$143K |
|
1089
Krystal Biotech
KRYS
$9.68B
| $361K | ﹤0.01% |
+6,400
| New | +$320K |
|
1090
Radware
RDWR
$1.2B
| $359K | ﹤0.01% |
13,150
-12,250
| -48% | -$306K |
|
1091
Arcutis Biotherapeutics
ARQT
$3.3B
| $358K | ﹤0.01% |
+12,400
| New | +$304K |
|
1092
Rhythm Pharmaceuticals
RYTM
$7.77B
| $357K | ﹤0.01% |
12,000
-600
| -5% | -$15.2K |
|
1093
Morningstar
MORN
$7.33B
| $356K | ﹤0.01% |
1,600
| – | – |
|
1094
OneSpan
OSPN
$601M
| $355K | ﹤0.01% |
17,200
-16,050
| -48% | -$345K |
|
1095
Korro Bio
KRRO
$196M
| $354K | ﹤0.01% |
+200
| New | +$264K |
|
1096
Meritage Homes
MTH
$4.81B
| $349K | ﹤0.01% |
8,164
+6,124
| +300% | +$290K |
|
|
ATNX
1097
DELISTED
Athenex, Inc. Common Stock
ATNX
| $349K | ﹤0.01% |
1,595
+700
| +78% | +$172K |
|
1098
Pricesmart
PSMT
$5.33B
| $346K | ﹤0.01% |
+3,791
| New | +$298K |
|
1099
Arcturus Therapeutics
ARCT
$214M
| $343K | ﹤0.01% |
+8,100
| New | +$549K |
|
|
PRVB
1100
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $342K | ﹤0.01% |
+20,000
| New | +$300K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2020 Portfolio in Review
As of Q4 2020, DekaBank Deutsche Girozentrale held 1,386 positions worth $26.6B, up 18% from $22.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.26B of net new capital in Q4 2020, opening 198 new positions and adding to 571 existing holdings. Its largest new stake was SPX Corp: 295,000 shares worth $15.8M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alibaba, an estimated $61M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2020 buy was SPX Corp: 295,000 shares worth $15.8M.
- DekaBank Deutsche Girozentrale added most to Abbott in Q4 2020, an estimated $116M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2020 reduction was Alibaba, cutting an estimated $61M.
- DekaBank Deutsche Girozentrale fully exited First Solar in Q4 2020, selling an estimated $5.53M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $26.6B portfolio in Q4 2020.
- DekaBank Deutsche Girozentrale opened 198 new positions and closed 55 in Q4 2020.
- DekaBank Deutsche Girozentrale's portfolio value rose 18% quarter-over-quarter to $26.6B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2020, filed 12 Mar 2021.